帕米膦酸二钠葡萄糖注射液致过敏性休克 1 例分析

doi:10.19803/j.1672-8629.20240106

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (10): 1172-1174.
DOI: 10.19803/j.1672-8629.20240106

帕米膦酸二钠葡萄糖注射液致过敏性休克 1 例分析

刘猛¹, 方可¹, 严家菊¹, 刘梦¹, 何曼云¹, 魏良兵^2,*

¹皖西卫生职业学院附属医院临床药学部,安徽六安 237008;
²安徽中医药大学第一附属医院药学部,安徽合肥 230031

收稿日期:2024-02-22 出版日期:2024-10-15 发布日期:2024-10-14
通讯作者: ^*魏良兵,男,副主任药师·硕导,新药研发与临床药学。E-mail: wlb0101@163.com
作者简介:刘猛,男,硕士,副主任药师,药事管理与临床药学。
基金资助:
安徽省教育厅高校科学研究项目（2022YJZR002）; 安徽省高校优秀拔尖人才培育重点项目（gxyqZD2022119）

One case of anaphylactic shock caused by pamidronate disodium glucose injection

LIU Meng¹, FANG Ke¹, YAN Jiaju¹, LIU Meng¹, HE Manyun¹, WEI Liangbing^2,*

¹Department of Clinical Pharmacy, Affiliated Hospital of West Anhui Health Vocational College, Lu'an Anhui 237008, China;
²Department of Pharmacy, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei Anhui 230031, China

Received:2024-02-22 Online:2024-10-15 Published:2024-10-14

摘要/Abstract

摘要： 目的探讨帕米膦酸二钠致过敏性休克的发生特点,为临床防治不良反应和安全用药提供参考。方法分析1例帕米膦酸二钠导致过敏性休克的病例,根据国家药品不良反应监测中心评价方法进行关联性评价,文献回顾帕米膦酸二钠常见不良反应和致过敏性休克的发病机制,讨论原因及防治措施。结果根据患者的临床表现及药物与用药时间的关联性,考虑帕米膦酸二钠导致过敏性休克可能性大,患者经积极救治后,过敏性休克症状得到缓解。结论临床应用帕米膦酸二钠应警惕发生过敏性休克的风险,用药期间加强不良反应监测,促进临床安全合理用药。

关键词: 帕米膦酸二钠, 注射液, 过敏性休克, 严重过敏, 药品不良反应, 病例报告

Abstract: Objective To investigate the characteristics of anaphylactic shock triggered by pamidronate disodium in order to provide data for the prevention and treatment of adverse reactions and ensure safe medications. Methods One case of anaphylactic shock induced by pamidronate disodium was reported, with the correlations assessed using the evaluation method recommended by the National Adverse Drug Reaction Monitoring Center. Additionally, literature on the common adverse reactions and pathogenesis related to pamidronate disodium was reviewed to explore the potential causes and preventive strategies. Results The patient's clinical conditions and the timing of drug administration strongly suggested that pamidronate disodium was the likely cause of anaphylactic shock,so immediate and effective treatment was offered to alleviate the symptoms. Conclusion Clinicians who prescribe pamidronate disodium should be alert to the risk of anaphylaxis. It is crucial to enhance monitoring of adverse reactions and ensure the availability of emergency medications and equipment during treatment.

Key words: pamidronate disodium, injection, anaphylactic shock, severe allergy, adverse drug reaction, case report

中图分类号:

刘猛, 方可, 严家菊, 刘梦, 何曼云, 魏良兵. 帕米膦酸二钠葡萄糖注射液致过敏性休克 1 例分析[J]. 中国药物警戒, 2024, 21(10): 1172-1174.

LIU Meng, FANG Ke, YAN Jiaju, LIU Meng, HE Manyun, WEI Liangbing. One case of anaphylactic shock caused by pamidronate disodium glucose injection[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1172-1174.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240106

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I10/1172

参考文献

[1] TIAN QH, LU YY, YAN BC, et al.Integrative bioinformatics analysis reveals that miR-524 -5p/MEF2C regulates bone metastasis in prostate cancer and breast cancer[J]. Comput Math Methods Med, 2022, 2022: 5211329.
[2] SHUPP AB, NEUPANE M, AGOSTINI LC, et al.Stromalderived extracellular vesicles suppress proliferation of bone metastatic cancer cells mediated by ERK2[J]. Molecular Cancer Research, 2021, 19(10): 1763-1777.
[3] YANG W, ZUOLEI T, RONGQIN M, et al.Side effects of incardronate disodium compared to pamidronate disodium in the treatment of bone metastasis pain: a systematic review and meta-analysis[J]. Annals of Palliative Medicine, 2021, 10(11): 11950-11959.
[4] POINTER KB, KATIPALLY RR, BESTVINA CM, et al.Evaluation of initial metastatic tumor location and radiation response to determine outcomes in patients who received combination stereotactic body radiotherapy and immunotherapy for NSCLC[J]. International Journal of Radiation Oncology, Biology, Physics, 2021, 111(3S): 449
[5] SHROPSHIRE DB, ACOSTA FM, FANG K, et al.Association of adenosine signaling gene signature with estrogen receptor-positive breast and prostate cancer bone mctastasis[J]. Front Med(Lausanne), 2022, 9: 965429.
[6] SARKAR S, PAL R, MAHATA S, et al.Evaluation of numerical rating scale and neuropathic pain symptom inventory pain scores in advanced ovarian carcinoma patients undergoing surgery and first-line chemotherapy[J]. J Clin Transl Res, 2022, 8(1): 54-60.
[7] SHE Y, GOU XQ, AN ZM, et al.A case of hyperthermia induced by sodium pamidronate and a review of the literature[J]. West China Medical Journal(华西医学), 2008(6): 1420.
[8] MA Y, FENG YF, SUN CH.Muscle pain caused by the injectable pamidronate disodium[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2011, 8(1): 56-57.
[9] ZHANG YZ, ZHOU X.A case analysis of partial intestinal obstruction induced by disodium pamidronate[J]. Clinical Misdiagnosis & Mistherapy(临床误诊误治), 2015, 28(6): 76-77.
[10] XU Z, SHI MQ, TANG YQ. A case of severe hypocalcemia induced by disodium pamidronate[J]. Chinese Journal of Clinical Pharmacology and Therapeutics(中国临床药理学杂志), 2011, 27(8): 614, 617.
[11] XIE SJ, KAPLAN JA.Anterior uveitis and diffuse scleritis after pamidronate infusion[J]. Canadian Medical Association. Journal, 2023, 195(49): E1722-E1722.
[12] FAN DM.Guidelines for Integrated Diagnosis and Treatment of Cancer in China(中国肿瘤整合诊治指南)[M]. Tianjin: Tianjin Science and Technology Press, 2023.
[13] XU RH, LI J, MA J, et al.Guidelines for the Diagnosis and Treatment of Common Malignant Tumors 2023 by the Chinese Society of Clinical Oncology (CSCO(中国临床肿瘤学会常见恶性肿瘤诊方指南2023版)[M]. Beijing: People's Medical Publishing House, 2023.
[14] LI X, MA Q, YIN J, et al.A clinical practice guideline for the emergency management of anaphylaxis (2020)[J]. Front Pharmacol, 2022, 13: 845689.
[15] WEI J, WANG YX.An overview of the evaluation methods for the causality of adverse drug reactions[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2011, 8(10): 600-603.
[16] GAO Q, DUAN J, XU BP, et al.Interpretation of World Allergy Organization anaphylaxis guidance 2020[J]. Chinese Journal of Applied Clinical Pediatrics, 2021, 36(6): 431-437.
[17] Department of Health and Public Services, USA. Common Terminology Criteria for Adverse Events (CTCAE) Version 5. 0[EB/OL]. (2017-11-27) [2021-06-20]. http://guide.medlive.cn/.
[18] LI P, XIAO B, TANG Y, et al.Analysis of acute phase side-effects of diphosphonate treatment in elderly patients with primary osteoporosis[J]. Journal of Chinese Physician(中国医师杂志), 2016, 18(3): 362-365.
[19] YANG LD.A case analysis of allergic shock induced by risedronate sodium tablets[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(7): 795-798.
[20] CARDONA V, ANSOTEGUI I J, EBISAWA M, et al.World allergy organization anaphylaxis guidance 2020[J]. World Allergy Organ J, 2020, 13(10): 100472.
[21] DODD A, HUGHES A, SARGANT N, et al.Evidence update for the treatment of anaphylaxis[J]. Resuscitation, 2021, 163: 86-96.
[22] XU XX, HE KW, ZHENG Y, et al.A case of Shock induced by betahistine hydrochloride injection combined with zoledronic acid injection[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2022, 39(9): 1224-1225.

帕米膦酸二钠葡萄糖注射液致过敏性休克 1 例分析

One case of anaphylactic shock caused by pamidronate disodium glucose injection

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	魏曼莉, 吕林艳, 郑志远, 尹纪业, 麦志雄. 血栓通注射液临床前遗传毒性研究[J]. 中国药物警戒, 2024, 21(9): 1014-1018.
[2]	孟康康, 夏玉坤. 昂丹司琼制剂安全性风险分析[J]. 中国药物警戒, 2024, 21(9): 1034-1038.
[3]	吴凡, 付林杰, 祝赫, 徐梦艳. 基于美国FAERS和日本JADER数据库的内皮素受体拮抗剂不良事件信号分析[J]. 中国药物警戒, 2024, 21(9): 1056-1063.
[4]	卢靖, 喻珊珊, 童菲, 林卓慧, 宋路瑶. 达格列净片致严重便秘1例分析[J]. 中国药物警戒, 2024, 21(9): 1071-1074.
[5]	刘婷, 曹忠强, 何文佳, 袁秀丽, 陈泽彬, 李学娟. 培门冬酶注射液致急性重症胰腺炎1例分析[J]. 中国药物警戒, 2024, 21(9): 1075-1077.
[6]	刘毅, 刘晓强, 姚晓, 李选堂, 郭贤辉, 耿颖, 裴宇盛. 溴己新注射剂临床配伍用药研究[J]. 中国药物警戒, 2024, 21(8): 884-887.
[7]	魏芬芳, 吴文宇, 李丽敏, 唐碧雨, 吴建茹. 国外药品获益-风险评价方法概述与启示[J]. 中国药物警戒, 2024, 21(8): 900-905.
[8]	王玉玺, 张宗林, 王颖丽, 陈亚飞, 李俊生, 霍艳飞, 谢彦军, 刘文启. 560例脉络舒通丸不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 921-924.
[9]	赵俊, 董丽, 王洋, 梁瑜, 杨雪, 李恩泽. 艾司洛尔不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 925-930.
[10]	张乾, 恽渊, 何恋. 1例利培酮致高泌乳素血症患者的药学监护[J]. 中国药物警戒, 2024, 21(8): 936-938.
[11]	晁滢, 张学梅, 张成健, 王贝. 注射用头孢曲松钠致儿童输尿管结石及胆囊结石1例分析[J]. 中国药物警戒, 2024, 21(8): 943-945.
[12]	郭海嬿, 何波, 闫鸿丽, 杨雪婷. 稳心颗粒致持续性呃逆1例分析[J]. 中国药物警戒, 2024, 21(8): 946-948.
[13]	王丹, 董铎, 田春华. 我国药物警戒制度发展历程和思考[J]. 中国药物警戒, 2024, 21(7): 735-740.
[14]	邵波, 郭晓昕. 中药药物警戒回顾与思考[J]. 中国药物警戒, 2024, 21(7): 741-745.
[15]	阿拉腾花, 王振兴, 张晓朦, 世伟, 席成伟, 王聪慧, 王立群, 张冰. 基于药品不良反应监测数据的心脏器官伤害风险信号挖掘分析[J]. 中国药物警戒, 2024, 21(7): 752-758.